Evidence map›Paper›PMID 25200293›Full record

ReviewDiabetes, obesity & metabolism2014

Brain glucose sensing, glucokinase and neural control of metabolism and islet function.

E O Ogunnowo-Bada, N Heeley, L Brochard, M L Evans

Open access · hybridAbstract readReview
In one paragraph

Review in Diabetes, obesity & metabolism, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Nutrient sensors and their crosstalk.Experimental & molecular medicine · 2023
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Glucose-Sensing in the Reward System.Frontiers in neuroscience · 2017
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

E O Ogunnowo-BadaWellcome Trust-MRC Institute of Metabolic Science, IMS Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.
N Heeley
L Brochard
M L Evans
Wellcome/MRC Institute of Metabolic Science · GBWellcome Trust · GB

Funding

Medical Research Council G0600717Wellcome Trust 100574
6 · The paper itself

Abstract

It is increasingly apparent that the brain plays a central role in metabolic homeostasis, including the maintenance of blood glucose. This is achieved by various efferent pathways from the brain to periphery, which help control hepatic glucose flux and perhaps insulin-stimulated insulin secretion. Also, critically important for the brain given its dependence on a constant supply of glucose as a fuel--emergency counter-regulatory responses are triggered by the brain if blood glucose starts to fall. To exert these control functions, the brain needs to detect rapidly and accurately changes in blood glucose. In this review, we summarize some of the mechanisms postulated to play a role in this and examine the potential role of the low-affinity hexokinase, glucokinase, in the brain as a key part of some of this sensing. We also discuss how these processes may become altered in diabetes and related metabolic diseases.

Indexed as

Feedback, PhysiologicalModels, NeurologicalAnimalsBrainDiabetes MellitusEnergy MetabolismGlucokinaseGlucoseHumansHypoglycemiaInsulinInsulin SecretionIslets of LangerhansNerve Tissue ProteinsNeurogliaNeuronsGlucokinaseGlucoseInsulinNerve Tissue Proteinsglucokinaseglucose sensingglucose-stimulated insulin secretionhypoglycaemiahypothalamusinsulin

Identifiers

PMID25200293
PMCPMC4405079
OpenAlexW2018893256

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.